Advair Diskus 250/50 (Fluticasone 250 µg and salmeterol 50 µg inhalation powder)

News
Article

Novel therapy for COPD

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Logan Lutton
August 13th 2025
Article

Read More

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Remote Care Advancement for Heart Failure, COPD and Diabetes Patients

Briana Contreras
August 13th 2025
Podcast

Listen

Pulmonary Fibrosis Foundation Celebrates 25 Years

Pulmonary Fibrosis Foundation Celebrates 25 Years

Keith Loria
August 13th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
August 13th 2025
Podcast

Listen

FDA Approves Ajovy for Childhood Migraine Prevention

FDA Approves Ajovy for Childhood Migraine Prevention

Logan Lutton
August 13th 2025
Article

Read More

ZAKARIYAE-stock@adobe.com

FDA Grants Accelerated Approval For Targeted Drug for Rare Brain Tumor

Denise Myshko
August 13th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.